Wendall Wierenga sold $36k of CYTK
director at CYTOKINETICS INC. 742 shares at an average of $48.61, traded Dec 16, 2024, filed Dec 16, 2024.
Score components
- +15RoleDirector
- +6Trade size$36k at market
- 0Share of holdings soldSold 2.9% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-24-029523, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | MOption exercise Common Stock10b5-1 | +742 | $7.37 | $5,469 | 25,301 | Dec 16, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -742 | $48.61 | $36k | 24,559 | Dec 16, 2024 |
| Dec 16, 2024 | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -742 | $0.00 | $0 | 0 | Dec 16, 2024 |
Related signals
Other insiders at CYTOKINETICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 23Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Robert I Blum President & CEO | $491k | 7,500 | |
| 8Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Fady Ibraham Malik EVP Research & Development | $239k | 3,500 | |
| 40Moderate | sell 410b5-1 | CYTK CYTOKINETICS INC | Robert I Blum President & CEO | $7.3M | 105,426 | |
| 23Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Robert E Landry director | $72k | 1,000 | |
| 18Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Robert E Landry director | $75k | 1,000 | |
| 8Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Fady Ibraham Malik EVP Research & Development | $264k | 3,500 | |
| 35Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | B Lynne Parshall director | $357k | 5,000 | |
| 40Moderate | sell 310b5-1 | CYTK CYTOKINETICS INC | Robert I Blum President & CEO | $611k | 15,000 | |
| 4Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Fady Ibraham Malik EVP Research & Development | $87k | 2,000 | |
| 45Moderate | sell 410b5-1 | CYTK CYTOKINETICS INC | Robert I Blum President & CEO | $1.1M | 25,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.